Evidence map›Paper›PMID 40385552›Full record

ArticleMicroplastics and nanoplastics2025

Size- and polymer-dependent toxicity of amorphous environmentally relevant micro- and nanoplastics in human bronchial epithelial cells.

I F Gosselink, P Leonhardt, E M Höppener, R Smelt, M J Drittij, M Davigo, G G H van den Akker, I M Kooter, T J M Welting, F J van Schooten and 1 more

Abstract read
In one paragraph

Article in Microplastics and nanoplastics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

I F Gosselink *Department of Pharmacology and Toxicology, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6629 ER Maastricht, the Netherlands.
P Leonhardt *Department of Pharmacology and Toxicology, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6629 ER Maastricht, the Netherlands.
E M HöppenerNetherlands Organisation for Applied Scientific Research, TNO, 3584 CB Utrecht, the Netherlands.
R SmeltDepartment of Pharmacology and Toxicology, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6629 ER Maastricht, the Netherlands.
M J DrittijDepartment of Pharmacology and Toxicology, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6629 ER Maastricht, the Netherlands.
M DavigoDepartment of Pharmacology and Toxicology, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6629 ER Maastricht, the Netherlands.
G G H van den AkkerLaboratory of Experimental Orthopedics, Department of Orthopedic Surgery, Maastricht University, 6229 ER Maastricht, the Netherlands.
I M KooterDepartment of Pharmacology and Toxicology, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6629 ER Maastricht, the Netherlands.
T J M WeltingLaboratory of Experimental Orthopedics, Department of Orthopedic Surgery, Maastricht University, 6229 ER Maastricht, the Netherlands.
F J van SchootenDepartment of Pharmacology and Toxicology, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6629 ER Maastricht, the Netherlands.
A H V RemelsDepartment of Pharmacology and Toxicology, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6629 ER Maastricht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Knowledge of the toxicological impact of micro- and nanoplastics (MNPs) on the human airway epithelium is limited and almost exclusively based on experiments applying high doses of spherical polystyrene (PS) particles. In this study, we investigated the toxicity of a broad size range of amorphous MNPs generated from different environmentally-relevant polymers. Methods: Bronchial epithelial cells (BEAS-2B) were exposed to three different doses of polyvinylchloride (PVC), polypropylene (PP), or polyamide (PA) particles (< 1 μm-10 μm), as well as leachates from these polymers. Toxicity was evaluated by assessment of cytotoxicity, inflammation (IL-8 release and inflammatory gene expression) and oxidative stress (DCFH-DA assay and antioxidant gene expression). Furthermore, the molecular mechanism behind MNP-induced inflammation was investigated by studying activation of two well-known inflammation related transcriptional factors (NF-κB and AP-1). Results: Only PA nanoplastics induced significant cell death, IL-8 secretion and inflammatory gene expression compared to vehicle control. PA-induced inflammation was accompanied by NF-κB, but not AP-1, transcriptional activity. PA did not increase cellular ROS levels; however, it did lead to increased expression of the antioxidant gene superoxide dismutase 2. In addition to PA, exposure to < 1 µm and 1-5 µm PP particles resulted in elevated IL-8 secretion, likely due to the presence of talc added as filler. None of the leachates affected cytotoxicity or inflammation. Conclusion: Toxicity of MNPs to human bronchial epithelial cells was dependent on polymer type, size and dose. Nanoplastics, especially PA, were more toxic to bronchial epithelial cells than microplastics and induced cytotoxicity and an inflammatory response. Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1186/s43591-025-00126-9.

Indexed as

InflammationInhalation toxicologyNF-ĸBPolyamidePolypropylenePolyvinylchloride

Identifiers

PMID40385552
PMCPMC12081513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.